Drucker Wealth, a renowned financial advisory firm, has launched its independent Registered Investment Advisor (RIA) in New Jersey, marking a significant shift in the investment world. With assets worth $750 million and a historic link with HTK, Drucker Wealth is set to offer personalized, client-centric financial services under the leadership of father-son duo, Lance and Gideon Drucker.

In a bold affirmation of international trust, Israel launches a record $8 billion bond sale, sparking a $25 billion investment demand amidst ongoing conflict, underscoring the nation's economic resilience and the global market's robust confidence.

A recent report by the American Academy of Actuaries calls for a reevaluation of the PBGC premium structure to enhance the stability of pension plans and ensure the financial well-being of American retirees.

Exploring the escalating legal battle between Greensill Capital’s founder, Lex Greensill, and the UK government, amidst investigations and calls for regulatory reform in the wake of the firm’s collapse and controversial lobbying activities.

In the face of operational difficulties, notably at the Cobre Panama mine, Franco-Nevada Corporation showcases solid financial results and a sustainable growth trajectory, reinforced by strategic expansions and a strong commitment to ESG leadership.

In-depth report reveals the monocrystalline solar cell market's significant growth, propelled by technological advances and rising eco-consciousness, signaling a shining era of energy transformation.

Argyle, a leading fintech company specializing in income and employment verification, has secured a landmark $30 million funding round, bringing their total capital to over $100 million. Backed by key investors like Rockefeller Capital Management, Argyle is set to enhance its cutting-edge services amidst the challenging climate of the fintech industry.

An assertive activist fund spearheaded by Yoshiaki Murakami has become the dominant shareholder of Aozora Bank Ltd., igniting a battle with short sellers as it challenges prevailing market norms in Japan's financial industry. A closer look reveals a potentially transformative movement shaping the country's corporate governance.

In an unprecedented surge of medical breakthroughs, the landscape of healthcare is undergoing a monumental shift with the introduction of innovative cancer treatments like Lumakras for lung cancer, promising HIV therapies, and cutting-edge research in gene editing and anti-aging. This new era brings hope for combating the most challenging diseases and redefining human health and longevity.

Recent shifts in market dynamics have seen leveraged funds unwinding their short positions in Treasury futures, signaling a significant realignment in financial strategies, with analysts noting a reduction in net duration shorts and a rise in cash market long positions.